Page last updated: 2024-11-06

tricaprin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tricaprin is a triglyceride composed of three capric acid (C10:0) molecules. It is a white, waxy solid at room temperature. It is often used as an emulsifier, lubricant, and emollient in personal care products. Tricaprin can be synthesized via esterification of glycerol with capric acid. It is also found naturally in some vegetable oils such as coconut oil and palm oil. Tricaprin has been shown to have potential antifungal and antibacterial properties. It is also being studied for its potential use in the treatment of skin conditions such as eczema and psoriasis. It is valued in cosmetics as a skin conditioning agent that imparts softness and smoothness to the skin. Research is ongoing to further understand its potential benefits and applications.'

tricaprin : A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by capric (decanoic) acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID69310
CHEBI ID77388
SCHEMBL ID126224
MeSH IDM0056583

Synonyms (84)

Synonym
decanoic acid, 1,2,3-propanetriyl ester
1,2,3-propanol tridecanoate
nsc 147475
glyceryl tricaprate
ai3-36968
brn 1717683
einecs 210-702-0
3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-ol,32-(4-(1,1,3,- 3-tetramethylbutyl)phenoxy)-
propane-1,2,3-triyl tridecanoate
glycerol tricaprin
621-71-6
dynasan 110
tricapric glyceride
decanoic acid,2,3-propanetriyl ester
capric acid triglyceride
glycerol tricaprate
nsc-147475
tricaprin
glycerol tridecanoate
decanoin, tri-
nsc147475
tridecanoin
T7517_SIGMA ,
glyceryl tridecanoate, >=99% (gc)
tridecanoin c10:0
1,2,3-tridecanoylglycerol
glyceryl tridecanoate
BMSE000566
1,2,3-tricaprinoylglycerol
glycerol tris(decanoate)
1,2,3-tridecanoyl-rac-glycerol
2,3-di(decanoyloxy)propyl decanoate
T0413
1,2,3-tridecanoyl-sn-sn-glycerol
1,2,3-tricaprinoyl-glycerol
1,2,3-tridecanoyl-sn-glycerol
LMGL03012617
decanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester
unii-o1pb8eu98m
4-02-00-01047 (beilstein handbook reference)
o1pb8eu98m ,
panacet 1000
tricaprin [inn]
tricaprinoylglycerol
triglyceride decanoate
capric triglyceride
tricaprin [inci]
captex 1000
decanoic acid triglyceride
capric triglyceride [vandf]
AKOS015899809
SCHEMBL126224
DTXSID1042651
tg(10:0/10:0/10:0)
tri-n-caprin
tg 10:0/10:0/10:0
glycerin tridecanoate
CHEBI:77388
2,3-bis(decanoyloxy)propyl decanoate #
mfcd00036239
2,3-bis(decanoyloxy)propyl decanoate
tricaprin, certified reference material, tracecert(r)
tricaprin, european pharmacopoeia (ep) reference standard
tricaprin 8000 microg/ml in pyridine
1,2, 3-propanetriyl-decanoate
2,3-bis(decanoyloxy)propyl decanoic acid
glycerol tridecanoic acid
glyceryl tridecanoic acid
tri-decanoin
1,2, 3-propanetriyl-decanoic acid
2,3-bis(decanoyloxy)propyl decanoate (acd/name 4.0)
FT-0704752
Q27146923
propane-1,2,3-triyl tris(decanoate)
BCP31609
tridecanoin;glycerol tricaprate
CCG-270027
CS-0083196
D92337
S5731
HY-N6660
propane-1,2,3-triyltris(decanoate)
1,2,3-tricaprinoylglycerol, 1,2,3-tridecanoylglycerol
BS-23875

Research Excerpts

Actions

ExcerptReferenceRelevance
"Tricaprin increase the rate of spreading of macrophages on glass. "( Effects of simple lipids on macrophages in vitro.
Smith, II; Stuart, AE, 1975
)
1.7

Bioavailability

ExcerptReferenceRelevance
"The purpose of this study was to develop novel solid lipid nanoparticle (SLN)-loaded dual-reverse thermosensitive hydrogel (DRTH) for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect."( Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Choi, HG; Choi, JY; Din, FU; Kim, DW; Kim, JO; Ku, SK; Mustapha, O; Park, JH; Rashid, R; Yong, CS, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
triglycerideAny glyceride resulting from the condensation of all three hydroxy groups of glycerol (propane-1,2,3-triol) with fatty acids.
decanoate esterA fatty acid ester resulting from the formal condensation of the carboxy group of decanoic acid (capric acid) with the hydroxy group of an alcohol or phenol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
De Novo Triacylglycerol Biosynthesis TG(10:0/10:0/10:0)510

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.11)18.7374
1990's4 (14.81)18.2507
2000's7 (25.93)29.6817
2010's11 (40.74)24.3611
2020's2 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.62 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index73.01 (26.88)
Search Engine Supply Index2.39 (0.95)

This Compound (42.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (11.11%)5.53%
Reviews1 (3.70%)6.00%
Case Studies1 (3.70%)4.05%
Observational0 (0.00%)0.25%
Other22 (81.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]